Eric Roos resumes & CV records
Resumes
Eric Roos
Eric Roos
Eric Roos
Eric Roos
Eric J Roos, 60Hassanamisco Indian Reservat, MA
Eric Roos Phones & Addresses
Grafton, MA
Menlo Park, CA
Marlborough, MA
Redwood City, CA
Shrewsbury, MA
Mentions for Eric J Roos
Publications & IP owners
Us Patents
Culture Dish And Bioreactor System
US Patent:
6730510, May 4, 2004
Filed:
Jul 2, 2002
Appl. No.:
10/189300
Inventors:
Eric Roos - Grafton MA
Christopher OReilly - Middleboro MA
Ruben Chevere - North Attleboro MA
Leon M. Wilkins - North Andover MA
Christopher OReilly - Middleboro MA
Ruben Chevere - North Attleboro MA
Leon M. Wilkins - North Andover MA
Assignee:
Organogenesis, Inc. - Canton MA
International Classification:
C12M 134
US Classification:
4352883, 4352975, 4353054
Abstract:
A bioreactor has a base for defining a well, a dish with a membrane suspended in the base, and a lid with gas permeable membranes and self-sealing ports.
Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US Patent:
8070827, Dec 6, 2011
Filed:
Oct 31, 2007
Appl. No.:
11/982268
Inventors:
Sonya Shortkroff - Braintree MA, US
Laurence J. B. Tarrant - Northampton MA, US
Eric J. Roos - Grafton MA, US
Robert Lane Smith - Palo Alto CA, US
Hans Peter Ingemar Claesson - Wayland MA, US
Laurence J. B. Tarrant - Northampton MA, US
Eric J. Roos - Grafton MA, US
Robert Lane Smith - Palo Alto CA, US
Hans Peter Ingemar Claesson - Wayland MA, US
Assignee:
Histogenics Corporation - Waltham MA
International Classification:
A61F 2/02
US Classification:
623 2372
Abstract:
A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A stand alone secondary scaffold implant or unit.
Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US Patent:
2009005, Feb 26, 2009
Filed:
Aug 20, 2008
Appl. No.:
12/194771
Inventors:
SONYA SHORTKROFF - Braintree MA, US
LAURENCE J. B. TARRANT - Northampton MA, US
ERIC J. ROOS - Grafton MA, US
ROBERT LANE SMITH - Palo Alto CA, US
HANS P. I. CLAESSON - Wayland MA, US
LAURENCE J. B. TARRANT - Northampton MA, US
ERIC J. ROOS - Grafton MA, US
ROBERT LANE SMITH - Palo Alto CA, US
HANS P. I. CLAESSON - Wayland MA, US
Assignee:
Histogenics Corporation - Waltham MA
International Classification:
A61F 2/28
A61B 19/00
A61B 17/08
A61B 19/00
A61B 17/08
US Classification:
623 1611, 128898, 606151
Abstract:
A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand alone secondary scaffold implant or unit for treatment of tissue defects.
Method For Use Of A Double-Structured Tissue Implant For Treatment Of Tissue Defects
US Patent:
2013025, Oct 3, 2013
Filed:
May 20, 2013
Appl. No.:
13/897816
Inventors:
Laurence J. B. Tarrant - Easthampton MA, US
Eric J. Roos - Grafton MA, US
Robert Lane Smith - Palo Alto CA, US
Hans P. I. Claesson - Wayland MA, US
Eric J. Roos - Grafton MA, US
Robert Lane Smith - Palo Alto CA, US
Hans P. I. Claesson - Wayland MA, US
Assignee:
HISTOGENICS CORPORATION - Waltham MA
International Classification:
A61L 27/44
A61L 27/54
A61L 27/56
A61L 27/54
A61L 27/56
US Classification:
424400, 514773, 514774, 424 937, 514 76, 514 113, 424 941
Abstract:
A method for use of a double-structured tissue implant or a secondary scaffold stand alone implant for treatment of tissue defects. The double-structured tissue implant comprising a primary scaffold and a secondary scaffold consisting of a soluble collagen solution in combination with a non-ionic surfactant generated and positioned within the primary scaffold. A method of use of a stand alone secondary scaffold implant or unit for treatment of tissue defects.
Transdermal Administration Of Buprenorphine
US Patent:
5069909, Dec 3, 1991
Filed:
Jun 20, 1990
Appl. No.:
7/540908
Inventors:
Kuldeepak Sharma - Mountain View CA
Samir D. Roy - Mountain View CA
Eric J. Roos - Redwood City CA
Samir D. Roy - Mountain View CA
Eric J. Roos - Redwood City CA
Assignee:
Cygnus Therapeutic Systems - Redwood City CA
International Classification:
A61F 1300
US Classification:
424449
Abstract:
Method and laminated composite for administering buprenorphine transdermally to treat pain. The composite comprises an impermeable backing layer and a reservoir layer containing buprenorphine and optionally a permeation enhancer combined with a pressure-sensitive adhesive with the amounts of buprenorphine and optional enhancer being sufficient to cause the buprenorphine to pass through the skin at a rate in excess of about 0. 05 mcg/cm. sup. 2 /hr.
Chemo-Mechanical Expansion Delivery System
US Patent:
5935593, Aug 10, 1999
Filed:
Oct 22, 1996
Appl. No.:
8/749758
Inventors:
Eyal S. Ron - Lexington MA
Eric Roos - Grafton MA
Matthew E. Schiller - Waltham MA
Michal Orkisz - Brighton MA
Anne Staples - Newtonville MA
Eric Roos - Grafton MA
Matthew E. Schiller - Waltham MA
Michal Orkisz - Brighton MA
Anne Staples - Newtonville MA
Assignee:
MedLogic Global Corporation - Colorado Springs CO
International Classification:
A61F 202
A61K 922
A61K 922
US Classification:
424423
Abstract:
System for delivery of a biologically active substance into an environment. First and second chambers are separated by a moveable partition. The first chamber includes a polymer gel network which undergoes a volume change in response to an environmental condition such as pH. The first compartment includes a screen or membrane for confining the polymer gel network while allowing communication with fluid in an environment. The second compartment contains a biologically active compound or drug which is delivered to the environment through an orifice in the second compartment. Upon the occurrence of the triggering environmental condition, the polymer gel network undergoes a volume change which moves the moveable partition expelling the drug through the orifice. Drug delivery is initiated and continues only when the appropriate environmental condition or trigger is met.
Loading Of Biologically Active Solutes Into Polymer Gels
US Patent:
5840338, Nov 24, 1998
Filed:
Nov 6, 1995
Appl. No.:
8/556130
Inventors:
Eric J. Roos - Grafton MA
Matthew E. Schiller - Waltham MA
Matthew E. Schiller - Waltham MA
International Classification:
A61K 910
A61K 4736
A61K 4734
A61K 4736
A61K 4734
US Classification:
424488
Abstract:
Polymer gel networks loaded with biologically active solutes in a manner that solute activity is maintained and protected from thermal and/or chemical degradation while in the gel network are provided. The invention also provides for effects of modulating parameters for loading safe responsive gel networks using loading solutions containing phase separating polymers.
Transdermal Formulations For Administering Prazosin
US Patent:
5688524, Nov 18, 1997
Filed:
Mar 10, 1993
Appl. No.:
8/028888
Inventors:
Tsung-Min Hsu - Union City CA
Eric J. Roos - Menlo Park CA
Eric J. Roos - Menlo Park CA
Assignee:
Cygnus, Inc. - Redwood City CA
International Classification:
A61F 1300
US Classification:
424449
Abstract:
Prazosin is formulated in solution with a akin permeation enhancer composition of: a sulfhydryl-containing compound, a fatty acid eater, and a polar solvent for transdermal administration to treat hypertension or benign prostatic hypertrophy. The formulation is employed in the form of a skin patch comprising (a) an impermeable backing layer, (b) a reservoir of the prazosin-enhancer solution, (c) a porous support member that retains the solution but is not a permeation barrier to the solution, a peripheral adhesive layer for affixing the patch to the skin, and a release liner layer.
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.